Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety of primary immunization with a DTwP-HBV/Hib vaccine in healthy infants: a prospective, open-label, interventional, phase IV clinical study.

Autor: Capeding MRZ; Department of Microbiology, Research Institute for Tropical Medicine, Muntinlupa City, Philippines., Gatchalian SR; Department of Pediatrics, Philippine General Hospital, Manila, Philippines., Aseron M; Department of Pediatrics, University of Perpetual Help Dalta Medical Center, Las Piñas City, Philippines., Lopez ALL; Institute of Child Health and Human Development, University of the Philippines Manila - National Institutes of Health, Philippines., Yu DC; De La Salle Medical and Health Sciences Institute, Cavite, Philippines., Garcia Ibe ME; St. Luke's Medical Center, Quezon City, Philippines., De Leon MN; Philippine Heart Center, Quezon City, Philippines., Modequillo M; Department of Pediatrics, Perpetual Succour Hospital, Cebu, Philippines., Flavier MEE; Department of Pediatrics, Southern Philippines Medical Center, Davao City, Philippines., Ong-Lim AL; Department of Pediatrics, Philippine General Hospital, University of the Philippines Manila, Philippines.

Publikováno v: Expert review of vaccines [Expert Rev Vaccines] 2022 May; Vol. 21 (5), pp. 685-692. Date of Electronic Publication: 2022 Mar 07.

Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age.

Autor: Bravo LC; University of the Philippines Manila, Manila, Philippines., Carlos JC; University of the East-Ramon Magsaysay Memorial Medical Center Incorporated, Manila, Philippines., Gatchalian SR; UP CM University of the Philippines, Manila, Department of Pediatrics. Philippine General Hospital, Philippines., Montellano MEB; Mary Chiles General Hospital, Sampaloc, Manila, Philippines., Tabora CFCB; Research Institute for Tropical Medicine, Muntinlupa City, Metro Manila, Philippines., Thierry-Carstensen B; Statens Serum Institut, 5 Artillerivej, 2300 Copenhagen S, Denmark. Electronic address: BTC@ssi.dk., Tingskov PN; Statens Serum Institut, 5 Artillerivej, 2300 Copenhagen S, Denmark. Electronic address: PNT@ssi.dk., Sørensen C; AJ Vaccines, 5 Artillerivej, 2300 Copenhagen S, Denmark. Electronic address: CHS@ajvaccines.com., Wachmann H; Larix A/S, Lyskær 8b, 2730 Herlev, Denmark. Electronic address: HEW@larixcro.com., Bandyopadhyay AS; Bill & Melinda Gates Foundation, Seattle, WA, USA. Electronic address: Ananda.bandyopadhyay@gatesfoundation.org., Nielsen PI; AJ Vaccines, 5 Artillerivej, 2300 Copenhagen S, Denmark. Electronic address: PXN@ajvaccines.com., Kusk MV; AJ Vaccines, 5 Artillerivej, 2300 Copenhagen S, Denmark. Electronic address: MHK@ajvaccines.com.

Publikováno v: Vaccine [Vaccine] 2020 Jan 16; Vol. 38 (3), pp. 530-538. Date of Electronic Publication: 2019 Nov 05.

Influenza in the Asia-Pacific region: Findings and recommendations from the Global Influenza Initiative.

Autor: Cowling BJ; School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: bcowling@hku.hk., Caini S; NIVEL, Dutch Institute for Health Services Research, Utrecht, The Netherlands., Chotpitayasunondh T; Queen Sirikit National Institute of Child Health, Ministry of Public Health, Bangkok, Thailand., Djauzi S; University of Indonesia, Jakarta Pusat, Indonesia., Gatchalian SR; University of the Philippines Manila, College of Medicine, Philippine General Hospital, Manila City, Philippines., Huang QS; Institute of Environmental Science and Research (ESR), Wallaceville, Upper Hutt, New Zealand., Koul PA; Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India., Lee PI; National Taiwan University Children's Hospital, Taipei, Taiwan., Muttalif AR; Institute of Respiratory Medicine, Kuala Lumpur, Malaysia., Plotkin S; University of Pennsylvania, Doylestown, PA, USA.

Publikováno v: Vaccine [Vaccine] 2017 Feb 07; Vol. 35 (6), pp. 856-864. Date of Electronic Publication: 2017 Jan 09.

Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children.

Autor: Gatchalian SR; Research Institute for Tropical Medicine, DOH Compound, Alabang, Muntinlupa City, Philippines. sally.r.gatchalian@gsk.com, Ramakrishnan G, Bock HL, Lefevre I, Jacquet JM

Publikováno v: Human vaccines [Hum Vaccin] 2010 Aug; Vol. 6 (8), pp. 664-72.